A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis

This publication has 57 references indexed in Scilit:

• Effects of ursodeoxycholic acid in combination with vitamin E on adipokines and apoptosis in patients with nonalcoholic steatohepatitis
  Liver International, 2009
• Comparison of blood tests for liver fibrosis specific or not to NAFLD
  Journal of Hepatology, 2009
• High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective
  Journal of Hepatology, 2008
• The NAFLD fibrosis score
  Hepatology, 2007
• The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
  Gastroenterology, 2005
• The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver diseasePowell EE, Cooksley WGE, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years [Hepatology 1990; 11:74–80]
  Journal of Hepatology, 2004
• Activation of the Metallothionein IIA Promoter and Other Key Stress Response Elements by Ursodeoxycholate in HepG2 Cells: Relevance to the Cytoprotective Function of Ursodeoxycholate
  Pharmacology, 2002
• Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial
  Journal of Hepatology, 1999
• Chronic Administration of Ursodeoxycholic and Tauroursodeoxycholic Acid Changes Microsomal Membrane Lipid Content and Fatty Acid Composition in Rats
  Biochemical and Biophysical Research Communications, 1996
• Ursodeoxycholic Acid Therapy in Cystic Fibrosis—Associated Liver Disease: A Dose–Response Study
  Hepatology, 1992